References
- Valent P, Horny H-P, Escribano L, Longley BJ, Li CY, Schwartz LB. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001; 25:603-25. Google Scholar
- Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res. 2003; 27:635-41. Google Scholar
- Horny H-P, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol. 1998; 22:1132-40. Google Scholar
- Horny HP, Valent P. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res. 2001; 25:543-51. Google Scholar
- Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny HP. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res. 2001; 25:529-36. Google Scholar
- Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci (USA). 1986; 83:4464-8. Google Scholar
- Horny HP, Greschniok A, Jordan JH, Menke DM, Valent P. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study. J Clin Pathol. 2003; 56:103-6. Google Scholar
- Escribano L, Diaz-Agustin B, Bellas C, Navalon R, Nunez R, Sperr WR. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res. 2001; 25:563-70. Google Scholar
- Krauth MT, Agis H, Aichberger KJ, Simonitsch-Klupp I, Muellauer L, Mayerhofer M. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis. Hum Pathol. 2006; 37:439-47. Google Scholar
- Sotlar K, Horny HP, Simonitsch I, Krokowski M, Aichberger KJ, Mayerhofer M. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol. 2004; 28:1319-25. Google Scholar
- Fritsche-Polanz R, Jordan JH, Feix A, Sperr WR, Sunder- Plassmann G, Valent P. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol. 2001; 113:357-64. Google Scholar
- Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, Van ‘t Wout JW, Verhoef G, Gerrits WB. Cladribine therapy for systemic mastocytosis. Blood. 2003; 102:4270-6. Google Scholar
- Baghestanian M, Bankl H, Sillaber C, Beil WJ, Radaszkiewicz T, Fuereder W. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia. 1996; 10:159-66. Google Scholar
- Jordan JH, Walchshofer S, Jurecka W, Mosberger I, Sperr WR, Wolff K. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol. 2001; 32:545-52. Google Scholar
- Aichberger KJ, Mayerhofer M, Gleixner KV, Krauth MT, Gruze A, Pickl WF. Identification of mcl-1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by mcl-1 antisense oligonucleotides and synergism with PKC412. Blood. 2007; 109:3031-41. Google Scholar
- Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci (USA). 1995; 92:10560-4. Google Scholar